Health Care·Health Care Equipment·$45.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.81 | N/A | -1.46% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.81 | N/A | -1.46% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about current market dynamics impacting results. They remain committed to their strategic initiatives.
Management noted the challenging market conditions affecting performance.
They emphasized a focus on long-term growth despite short-term setbacks.
The earnings report indicates that IDEXX Labs faced some challenges, particularly reflected in their EPS miss. The stock reacted negatively, dropping 3.72%, likely due to investor concerns over market conditions and the lack of revenue data. Without updated guidance, investors may remain cautious about the company's near-term performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AMERIPRISE FINL INC
Apr 22, 2013